Consult Lhasa is delighted to announce the acquisition of Spektra Consultoria. The acquisition builds upon years of successful collaboration between Consult Lhasa, Lhasa Limited, and Spektra.

New Consult Lhasa Health-Based Exposure Limits (HBELs) service helps to manage cross-contamination in pharmaceutical manufacturing, defining threshold values for safer medicines.

Consult Lhasa, a wholly owned subsidiary of Lhasa Limited, has been launched to provide expert scientific risk assessments to the pharmaceutical industry. This launch marks a significant milestone in Lhasa Limited commitment to enabling informed decision-making on chemical safety.